Sabon Gwajin Maganin Maganin Ciwon Haihuwa don Mummunan Yanayin Hauka

Yarjejeniyar rarrabawa ta duniya tare da Saladax Biomedical tana kawo gwajin sa ido kan magungunan kashe kwayoyin cuta ga abokan cinikin Beckman Coulter.           

Beckman Coulter, shugaban bincike na asibiti na duniya, ya sanar da cewa zai gabatar da sabbin gwaje-gwajen magungunan kashe kwayoyin cuta ga dakunan gwaje-gwaje da likitocin don magance rashin biyan bukatar asibiti ga mutane miliyan 69 da ke da mummunar yanayin tabin hankali a duk duniya.

A cikin sabuwar yarjejeniya tare da Saladax Biomedical, Inc., Beckman Coulter zai rarraba gwaje-gwajen da aka tsara don auna matakan jini na magungunan antipsychotic da aka tsara don kula da marasa lafiya masu fama da tabin hankali (SMI), irin su Schizophrenia da Bipolar Disorder. Wadannan sababbin ƙididdiga an haɓaka su ta amfani da fasahar nanoparticle mai mahimmanci da kuma ƙarfafa masu sana'a na kiwon lafiya tare da bayanai don saka idanu da magungunan ƙwaƙwalwa da aka tsara a cikin maganin cututtuka: Clozapine, Risperidone / Paliperidone, Olanzapine, Quetiapine, Aripiprazole.

Gwaje-gwaje masu saurin gaske, masu inganci suna gudana akan masu nazarin sinadarai na asibiti na Beckman Coulter AU da rage lokacin juyawa don sakamakon gwajin majiyyaci zuwa sa'o'i maimakon kwanaki - yana haifar da babban nasara gudanarwa da kulawa da jiyya ga marasa lafiya da marasa lafiya.

Mummunan cutar tabin hankali babbar damuwa ce ga lafiyar jama'a. A duk duniya mutane miliyan 45 ne ke fama da cutar bipolar kuma mutane miliyan 1 na fama da schizophrenia. Marasa lafiya tare da schizophrenia ko bipolar ba tare da magani ba na iya fuskantar ƙarar alamun alamun da za su iya zama nakasa, mai yuwuwar haifar da ƙarin kulawar likita ko kuma na iya haifar da kashe kansa. Wadannan sababbin ƙididdiga suna taimakawa masu sana'a na kiwon lafiya suna kimanta ma'auni na jiyya da kuma amsawar maganin miyagun ƙwayoyi. 

Kathleen Orland, babban mataimakin shugaban kasa & babban manaja, sunadarai na asibiti da immunoassay, Beckman Coulter, ya ce: “Beckman Coulter's portfolio of therapeutic drugs monitoring assays yana ba da dakunan gwaje-gwaje da wuraren gwaje-gwajen gwaje-gwaje don inganta kulawar marasa lafiya ta hanyar tabbatar da sa ido kan jeri na warkewa. Dangantakarmu da Saladax tana faɗaɗa damar yin amfani da dakunan gwaje-gwaje da likitocin zuwa gwajin ƙwayar cuta don maganin cututtukan hauka, wanda babban buƙatun kiwon lafiya ne. ”

Sal Salamone, Shugaba kuma Wanda ya kafa, Saladax, ya ce: “Haɗin gwiwarmu da Beckman Coulter wani babban mataki ne na samar da waɗannan mahimman gwaje-gwajen maganin ƙwaƙwalwa ga ƙwararrun kiwon lafiya. Waɗannan gwaje-gwajen suna ba da bayanan ƙididdiga na kan lokaci don su iya yin ingantaccen kimantawa wanda zai inganta kula da marasa lafiya masu fama da tabin hankali."

Ana gabatar da gwaje-gwaje a duk faɗin Turai da Amurka, tare da shirye-shiryen faɗaɗa zuwa abokan cinikin Beckman Coulter a duniya. Da fatan za a tuntuɓi wakilin tallace-tallace na Beckman Coulter ko mai rarrabawa don bayani game da wannan samfur da samuwa a yankinku.